Global Renal Denervation Devices Market Revenue Expected To Reach $3 Billion By 2030
The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Will Be The Estimated Market Size Of The Renal Denervation Devices Market By 2030?
The renal denervation devices market size has experienced significant expansion in recent years. It is projected to climb from $0.74 billion in 2025 to $0.98 billion in 2026, achieving a compound annual growth rate (CAGR) of 32.5%. This market’s past growth is attributable to factors including the increasing occurrence of resistant hypertension, progress in catheter ablation technologies, a rise in clinical studies focused on renal denervation, the proliferation of interventional cardiology procedures, and greater understanding of non-pharmacological treatments for hypertension.
The renal denervation devices market is projected to experience substantial expansion in the coming years. This market is anticipated to achieve a valuation of $3.01 billion by 2030, exhibiting a notable compound annual growth rate (CAGR) of 32.4%. The drivers for this growth during the forecast period encompass an increasing number of regulatory clearances for renal denervation devices, their growing deployment in outpatient settings, the escalating need for enduring hypertension management strategies, the broadening of clinical data confirming their effectiveness, and heightened investment in advanced ablation systems. Significant developments expected in the forecast period include the wider acceptance of catheter-based hypertension treatments, the increased utilization of radiofrequency and ultrasound ablation technologies, a heightened emphasis on minimally invasive cardiovascular interventions, the proliferation of image-guided renal denervation techniques, and a stronger focus on enhancing procedural safety and precision.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10631&type=smp
What Are The Main Drivers Accelerating The Growth Of The Renal Denervation Devices Market?
The growing occurrence of hypertension is projected to fuel the expansion of the renal denervation devices market in the coming years. Hypertension, otherwise known as high blood pressure, is a medical condition where the force of blood against the vessel walls remains excessively high. Renal denervation, a catheter-based intervention, has become recognized as a potential therapeutic alternative for patients experiencing resistant hypertension. This procedure is a minimally invasive, investigational approach designed to treat hypertension that has not responded to pharmaceutical treatments. For example, information released in January 2025 by the Centers for Disease Control and Prevention, a US-based government entity, revealed that high blood pressure either contributed to or directly caused 664,470 deaths in the United States during 2023. Thus, the increasing prevalence of hypertension will stimulate the development of the renal denervation devices market.
What Segment Categories Are Evaluated In The Renal Denervation Devices Market Study?
The renal denervation devices market covered in this report is segmented –
1) By Product: Simplicity Renal Denervation System, EnligHTN, Vessix Renal Denervation System, Iberis Renal Sympathetic Denervation System, Paradise Renal Denervation System, Other Products
2) By Technology: Radio Frequency Ablation, Ultrasound Energy-Based RDN, Other Technologies
3) By End-Users: Hospitals, Cardiovascular research centre, Other End-Users
Subsegments:
1) By Simplicity Renal Denervation System: Catheter System, Accessories
2) By EnligHTN: Catheter System, Generator, Accessories
3) By Vessix Renal Denervation System: Balloon Catheter, Generator, Accessories
4) By Iberis Renal Sympathetic Denervation System: Catheter System, Accessories
5) By Paradise Renal Denervation System: Catheter System, Accessories
6) By Other Products: Emerging Technologies, Alternative Devices
What Trends Are Driving Changes In The Renal Denervation Devices Market?
Key companies active in the renal denervation devices market are prioritizing the development of ultrasound renal denervation (uRDN) to boost treatment efficacy, decrease procedural difficulties, and present a non-invasive choice over conventional renal denervation approaches. Ultrasound renal denervation (uRDN) enhances renal denervation devices by facilitating accurate, non-surgical energy delivery to renal nerves, effectively decreasing blood pressure while safeguarding surrounding tissues, and elevating patient safety and comfort throughout the procedure. For instance, in November 2023, Recor Medical Inc., a US-based medical technology company, unveiled the Paradise uRDN system, an innovative ultrasound renal denervation device engineered to treat hypertension in patients whose blood pressure goals have not been met through typical lifestyle modifications and medications. Incorporating hydrocooling technology to protect the renal artery during treatment, this system marks a substantial progression in the renal denervation devices market by providing a new, nonpharmacologic method for managing resistant hypertension and broadening available treatment options for patients.
Which Industry Players Are Present In The Renal Denervation Devices Market?
Major companies operating in the renal denervation devices market are Medtronic PLC, ReCor Medical Inc., Boston Scientific Corporation, Abbott Laboratories, Cordis Corporation, Terumo Corporation, Kona Medical Inc., St. Jude Medical LLC, Johnson & Johnson, Symple Surgical Inc., Cardiosonic Ltd., Mercator MedSystems Inc., Ablative Solutions Inc., Renal Dynamics Ltd., Vesalio LLC, Biotronik SE & Co. KG, Cook Medical LLC, Hansen Medical Inc., Merit Medical Systems Inc., AngioDynamics Inc., Covidien Ltd., Volcano Corporation
Access The Complete Renal Denervation Devices Market Report:
https://www.thebusinessresearchcompany.com/report/renal-denervation-devices-global-market-report
Which Region Commands The Largest Share Of The Renal Denervation Devices Market?
Europe was the largest region in the renal denervation devices market in 2025.Asia-Pacific is expected to be the fastest-growing region in the global renal denervation devices market report during the forecast period. The regions covered in the renal denervation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Customized Renal Denervation Devices Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/report/renal-denervation-devices-global-market-report
Browse Through More Reports Similar to the Global Renal Denervation Devices Market 2026, By The Business Research Company
Nephrology And Urology Devices Market Report 2026
Late Stage Chronic Kidney Disease Drugs Market Report 2026
Kidney Stone Retrieval Devices Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
